Neve K A, Altar C A, Wong C A, Marshall J F
Brain Res. 1984 Jun 4;302(1):9-18. doi: 10.1016/0006-8993(84)91280-0.
The binding of [3H]spiroperidol to rat coronal sections in vitro was investigated using two procedures: swabbing studies, in which the tissue sections are wiped from the microscope slides after incubation in the presence of [3H]spiroperidol, and autoradiographic studies, in which the autoradiographic negatives are analyzed using computer-assisted densitometry. In the swabbing studies, the pharmacological and kinetic properties of butaclamol-displaceable binding were investigated, and the following results suggest that [3H]spiroperidol binds specifically to only a single site within the basal forebrain of tissue sections and that the site is the dopamine D-2 receptor. The pseudo-first order and first order plots for the rate of association to and dissociation from tissue sections appeared to be linear. Dopamine antagonists, such as haloperidol and butaclamol, were much more effective than dopamine agonists or the serotonin S-2 ligand, ketanserin, in inhibiting [3H]spiroperidol binding. The ability of dopamine agonists to inhibit [3H]spiroperidol binding was markedly reduced by the guanine nucleotide, Gpp(NH)p. Saturation analysis of specific [3H]spiroperidol binding revealed a Kd and Bmax of 0.93 nM and 447 fmol/mg protein, and a Hill coefficient of 1.05. The findings are also compatible with the possibility that [3H]spiroperidol binds to several sites that have identical affinities for this ligand. Densitometric studies were used to assess the effect of lesions on [3H]spiroperidol binding in the neostriatum. Intrastriatal injection of kainic acid substantially reduced 1 microM (+)--butaclamol-displaceable binding, indicating that the receptors are in large part on intrinsic striatal neurons. Neostriatal [3H]spiroperidol binding was investigated 7 days after destruction of the mesotelencephalic dopamine system by the ventral tegmental injection of 6-hydroxydopamine. As determined by saturation analysis, the average values for Kd and Bmax were 0.66 nM and 1212 fmol/mg protein in the intact striatum, and 0.82 nM and 1504 fmol/mg in the denervated striatum. The finding of a significant 23.8% increase in receptor density by the end of the first postoperative week, a period during which behavioral supersensitivity to apomorphine increases rapidly, supports the hypothesis that a proliferation of D-2 receptors underlies the behavioral manifestations of denervation supersensitivity.
采用两种方法研究了[3H]螺哌啶醇与大鼠冠状切片的体外结合:擦拭研究,即在[3H]螺哌啶醇存在下孵育后,将组织切片从显微镜载玻片上擦拭下来;放射自显影研究,即使用计算机辅助光密度测定法分析放射自显影片。在擦拭研究中,研究了布他拉莫尔可置换结合的药理学和动力学特性,以下结果表明[3H]螺哌啶醇仅特异性结合组织切片基底前脑内的一个位点,且该位点是多巴胺D-2受体。与组织切片结合和解离速率的伪一级和一级图似乎呈线性。多巴胺拮抗剂,如氟哌啶醇和布他拉莫尔,在抑制[3H]螺哌啶醇结合方面比多巴胺激动剂或5-羟色胺S-2配体酮色林更有效。鸟嘌呤核苷酸Gpp(NH)p显著降低了多巴胺激动剂抑制[3H]螺哌啶醇结合的能力。对特异性[3H]螺哌啶醇结合的饱和分析显示,Kd和Bmax分别为0.93 nM和447 fmol/mg蛋白,希尔系数为1.05。这些发现也与[3H]螺哌啶醇结合到对该配体具有相同亲和力的几个位点的可能性相符。光密度测定研究用于评估损伤对新纹状体中[3H]螺哌啶醇结合的影响。纹状体内注射 kainic 酸可显著降低1 microM(+)-布他拉莫尔可置换结合,表明这些受体大部分位于纹状体内在神经元上。在腹侧被盖注射6-羟基多巴胺破坏中脑边缘多巴胺系统7天后,研究新纹状体中的[3H]螺哌啶醇结合。通过饱和分析确定,完整纹状体中Kd和Bmax的平均值分别为0.66 nM和1212 fmol/mg蛋白,去神经纹状体中为0.82 nM和1504 fmol/mg。术后第一周结束时受体密度显著增加23.8%,在此期间对阿扑吗啡的行为超敏反应迅速增加,这一发现支持了D-2受体增殖是去神经超敏反应行为表现基础的假说。